How many times should I follow up with a Founder (after networking)?

Don't follow a cold email the next morning. Give it 4 business days. Within 24 to 48 hours while they still remember your face or handle. After that, send a breakup note and archive it. A founder who wants it will answer a clean close more often than a fifth bump.

Should I mention a mutual connection in a cold email?

Only if the connection would be comfortable with it. Name-dropping someone who barely knows you can backfire. If you do mention them, say exactly how you know them in one clause and move on. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

How soon should I follow up after a networking event?

Within two days. After that you're a vague name from a badge. Mention where you met and the topic, send anything you promised, and keep the ask optional. If they wanted a pitch, they would have asked. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Is it okay to send this cold email on LinkedIn instead of email?

Yes if this founder is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals cold email?

Don't use consumer-startup slang. It's a credibility leak. Calling them a 'decision maker' or pitching like they're a Fortune 500 process. Don't dump a calendar link as the first follow-up unless they asked. Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Pharmaceuticals · Founder · After Networking

Cold Email for Pharmaceuticals Founder: After Networking

A cold email for a Pharmaceuticals Founder (after networking) is a short message that reopens the thread without making them do extra work. A cold email is a first-touch message to someone who didn't ask for it, so relevance has to show up before the pitch does. In this setting, that means speaking to follow-up that ignores MLR, off-label risk,

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this cold email work for a Pharmaceuticals Founder?

Lead with an observed trigger, not a compliment about their About page.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a founder actually reads: Short, vivid, one proof point max.
Remind them of the exact topic you both lingered on.
Show you understand their bottleneck in their language.

When should I send this to a Pharmaceuticals Founder?

Don't follow a cold email the next morning. Give it 4 business days. Within 24 to 48 hours while they still remember your face or handle. For this combo, treat "1-2 days" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a founder, Short, vivid, one proof point max. Tuesday through Thursday mid-morning local time is a safe default. After three touches with different value, send a breakup and archive.

What this Founder actually cares about

A founder in Pharmaceuticals is protecting runway, focus, and the company's early reputation. They context-switch constantly and reply to emails that reduce uncertainty. They can smell a template that was also sent to 400 peers. The hook that earns a look is a problem they personally still own because the team is small. The ask should stay at this size: a yes/no on timing, or a 15-minute working chat. Delete trigger: Calling them a 'decision maker' or pitching like they're a Fortune 500 process. They context-switch constantly and reply to emails that reduce uncertainty. They can smell a template that was also sent to 400 peers.

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Words that work: MLR, label, access, HCP, congress, promotional review. A thread that ignores follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick reads like every other vendor bump.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone human and specific.
Write the subject after the body so it matches the actual hook.
Time it for 1-2 days. Within 24 to 48 hours while they still remember your face or handle.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after networking note?

Opening with your company story is how cold email dies.
Don't dump a calendar link as the first follow-up unless they asked.
Don't use consumer-startup slang. It's a credibility leak.
Calling them a 'decision maker' or pitching like they're a Fortune 500 process.

How does this after networking scenario compare?

Dimension	For this template
Best send window	1-2 days
Ideal length	Short, vivid, one proof point max.
Primary ask	a yes/no on timing, or a 15-minute working chat
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Human and specific. Peer to peer, not vendor to 'target.'
Unlike cold email	You have a shared moment. Use it. Writing like a stranger wastes the introduction.
Unlike introduction	You already met. Don't re-introduce your whole bio.

What should I copy and send?

Copy-ready template

Subject

[Company Name] / time through MLR

Body

Hi [First Name],

Saw [trigger] and figured this might be on your plate.

In Pharmaceuticals, that usually shows up as follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. I don't need a demo. I can send a 6-line teardown of how [Company Name] might approach follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick.

Remind them of the exact topic you both lingered on.

Wrong person? Point me to whoever owns [pain].

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Name the situation and the business object, not your excitement. Something like "[Company Name] / time through MLR" outperforms "Just checking in" because a founder can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

Related templates

Want a custom draft instead? Try the email generator.